Skip to main content

Table 2 Intervention for AMS and AFS among overall hospitals (n = 39)

From: Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan

  Broad-spectrum antibioticsa Antifungals
PAF
 Yes 23 (59.0) 5 (12.8)
 No 16 (41.0) 34 (87.2)
Preauthorization
 Yes 4 (10.3) 1 (2.6)
 No 35 (89.7) 38 (97.4)
Notification
 Yes 37 (94.9) 2 (5.1)
 No 2 (5.1) 37 (94.9)
Intervention within 7 days
 Yes 17 (43.6) 3 (7.7)
 No 22 (56.4) 36 (92.3)
Intervention within 28 days
 Yes 34 (87.2) 10 (25.6)
 No 5 (12.8) 29 (74.4)
  1. Unless otherwise stated, data are presented as n (%)
  2. PAF prospective audit and feedback, AMS antimicrobial stewardship, AFS antifungal stewardship
  3. a3rd and 4th generation cephalosporins and piperacillin-tazobactam, carbapenem, intravenous quinolone